Research Lecture at Nobel Forum – Michael W. Young

CANCELLED

Research Lecture at Nobel Forum    Free admission

 12 October,CANCELLED

Michael W. Young

Richard and Jeanne Fisher Professor
Laboratory of Genetics, The Rockefeller University
New York, USA

http://lab.rockefeller.edu/young/

Title: “Genetic regulation of sleep and circadian rhythms”

Dr. Young studies circadian (~24 hour) clocks, which are endogenous mechanisms that time the recurring, daily activities observed in most organisms. Young’s research has shown how interactions among
Read more…

2019-01-21T20:29:32+00:00

Nobel Laureate Revisiting Lecture – Stanley B. Prusiner 2017

Nobel Laureate Revisiting Lecture

Tuesday, April 4th, 2017, at 4.30

Stanley B. Prusiner
Nobel Laureate in Physiology or Medicine 1997

Title: Quest for prion therapeutics in neurodegenerative diseases

Alzheimer’s (AD) and Parkinson’s diseases (PD) are the most common neuro-degenerative diseases (ND). Increasing evidence argues that both AD and PD are caused by prions. Ab and tau proteins undergo changes in conformation
Read more…

2021-05-12T19:37:39+00:00

Karolinska Research Lecture – Xiadong Wang 2017

Research Lecture at Nobel Forum                              

6 April, 16.30

Xiaodong Wang, Ph.D.

National Institute of Biological Sciences, #7 Science Park Road, Zhongguancun Life Science Park, Beijing 102206, China.

http://www.nibs.ac.cn

Title: “Programmed Cell Death in Diseases and Aging”

The longest ongoing research program of our laboratory studies apoptosis, i.e. caspase-mediated cell death. One of our most surprising findings of these
Read more…

2019-01-13T15:20:46+00:00

Karolinska Research Lecture – Hidde Ploegh 2017

Research Lecture at Nobel Forum
16 March, 16.30

Hidde L. Ploegh                                                              

Whitehead Institute for Biomedical Research
9 Cambridge Center, CAMBRIDGE, MA 02142, USA

http://ploeghlab.wi.mit.edu

 Title: “Imaging immunity”

Recent work in my laboratory has focused on applications of camelid-derived single domain antibodies. These protein, also referred to as VHHs or nanobodies, are small (~12 kDa), do not have a stringent requirement
Read more…

2019-01-13T15:21:05+00:00